The P-region and S6 of Kv3.1 contribute to the formation of the ion conduction pathway

Biophys J. 1994 Dec;67(6):2261-4. doi: 10.1016/S0006-3495(94)80710-6.

Abstract

The loop between transmembrane regions S5 and S6 (P-region) of voltage-gated K+ channels has been proposed to form the ion-conducting pore, and the internal part of this segment is reported to be responsible for ion permeation and internal tetraethylammonium (TEA) binding. The two T-cell K+ channels, Kv3.1 and Kv1.3, with widely divergent pore properties, differ by a single residue in this internal P-region, leucine 401 in Kv3.1 corresponding to valine 398 in Kv1.3. The L401V mutation in Kv3.1 was created with the anticipation that the mutant channel would exhibit Kv1.3-like deep-pore properties. Surprisingly, this mutation did not alter single channel conductance and only moderately enhanced internal TEA sensitivity, indicating that residues outside the P-region influence these properties. Our search for additional residues was guided by the model of Durell and Guy, which predicted that the C-terminal end of S6 formed part of the K+ conduction pathway. In this segment, the two channels diverge at only one position, Kv3.1 containing M430 in place of leucine in Kv1.3. The M430L mutant of Kv3.1 exhibited permeant ion- and voltage-dependent flickery outward single channel currents, with no obvious changes in other pore properties. Modification of one or more ion-binding sites located in the electric field and possibly within the channel pore could give rise to this type of channel flicker.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Binding Sites / genetics
  • Biophysical Phenomena
  • Biophysics
  • Electrochemistry
  • Female
  • In Vitro Techniques
  • Ion Transport
  • Kinetics
  • Mice
  • Molecular Sequence Data
  • Molecular Structure
  • Mutagenesis, Site-Directed
  • Neuropeptides*
  • Oocytes / metabolism
  • Potassium Channels / chemistry*
  • Potassium Channels / drug effects
  • Potassium Channels / genetics
  • Potassium Channels, Voltage-Gated*
  • Shaw Potassium Channels
  • Tetraethylammonium
  • Tetraethylammonium Compounds / pharmacology
  • Xenopus

Substances

  • Neuropeptides
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Shaw Potassium Channels
  • Tetraethylammonium Compounds
  • Tetraethylammonium